Philip W Fowler1, Mark S P Sansom1, Reinhart A F Reithmeier2. 1. Department of Biochemistry, University of Oxford , South Parks Road, Oxford OX1 3QU, U.K. 2. Department of Biochemistry, University of Toronto , 1 King's College Circle, Toronto, Ontario, Canada M5S 1A8.
Abstract
The first transmembrane (TM1) helix in the red cell anion exchanger (AE1, Band 3, or SLC4A1) acts as an internal signal anchor that binds the signal recognition particle and directs the nascent polypeptide chain to the endoplasmic reticulum (ER) membrane where it moves from the translocon laterally into the lipid bilayer. The sequence N-terminal to TM1 forms an amphipathic helix that lies at the membrane interface and is connected to TM1 by a bend at Pro403. Southeast Asian ovalocytosis (SAO) is a red cell abnormality caused by a nine-amino acid deletion (Ala400-Ala408) at the N-terminus of TM1. Here we demonstrate, by extensive (∼4.5 μs) molecular dynamics simulations of TM1 in a model 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine membrane, that the isolated TM1 peptide is highly dynamic and samples the structure of TM1 seen in the crystal structure of the membrane domain of AE1. The SAO deletion not only removes the proline-induced bend but also causes a "pulling in" of the part of the amphipathic helix into the hydrophobic phase of the bilayer, as well as the C-terminal of the peptide. The dynamics of the SAO peptide very infrequently resembles the structure of TM1 in AE1, demonstrating the disruptive effect the SAO deletion has on AE1 folding. These results provide a precise molecular view of the disposition and dynamics of wild-type and SAO TM1 in a lipid bilayer, an important early biosynthetic intermediate in the insertion of AE1 into the ER membrane, and extend earlier results of cell-free translation experiments.
The first transmembrane (TM1) helix in the red cell anion exchanger (AE1, Band 3, or SLC4A1) acts as an internal signal anchor that binds the signal recognition particle and directs the nascent polypeptide chain to the endoplasmic reticulum (ER) membrane where it moves from the translocon laterally into the lipid bilayer. The sequence N-terminal to TM1 forms an amphipathic helix that lies at the membrane interface and is connected to TM1 by a bend at Pro403. Southeast Asian ovalocytosis (SAO) is a red cell abnormality caused by a nine-amino acid deletion (Ala400-Ala408) at the N-terminus of TM1. Here we demonstrate, by extensive (∼4.5 μs) molecular dynamics simulations of TM1 in a model 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine membrane, that the isolated TM1 peptide is highly dynamic and samples the structure of TM1 seen in the crystal structure of the membrane domain of AE1. The SAO deletion not only removes the proline-induced bend but also causes a "pulling in" of the part of the amphipathic helix into the hydrophobic phase of the bilayer, as well as the C-terminal of the peptide. The dynamics of the SAO peptide very infrequently resembles the structure of TM1 in AE1, demonstrating the disruptive effect the SAO deletion has on AE1 folding. These results provide a precise molecular view of the disposition and dynamics of wild-type and SAOTM1 in a lipid bilayer, an important early biosynthetic intermediate in the insertion of AE1 into the ER membrane, and extend earlier results of cell-free translation experiments.
The anion
exchanger AE1 (also
called Band 3 or SLC4A1) is an abundant glycoprotein in the plasma
membrane of the red cell where it mediates the electro-neutral exchange
of chloride and bicarbonate ions.[1−3] Human protein contains
911 amino acids with a single N-glycosylation site at Asn642. The
protein consists of two domains: the amino-terminal cytosolic domain
that provides a link to the underlying cytoskeleton[4,5] and
the carboxyl-terminal membrane domain that spans the lipid bilayer
14 times[6−11] and is responsible for the anion transport function.[12] A structure of the membrane domain of humanAE1 has been recently elucidated by X-ray crystallography (Figure A) that confirms
the 14-TM model.[13]
Figure 1
Role of TM1 in the synthesis
of the transmembrane domain of AE1.
(A) Structure of the transmembrane region of AE1 or Band 3. (B) Sequence
alignment between the sequences of the wild type and the SAO mutant
in the region of TM1. The SAO AE1 mutant is missing nine residues
(Ala400–Ala408) from the N-terminus of transmembrane segment
1 (TM1). The numbering refers to the wild-type sequence. The three
proline residues are highlighted, as are two key aspartate residues.
(C) Scanning N-glycosylation mutagenesis experiments[35] suggest TM1 acts as a signal-anchor sequence during AE1
biosynthesis. TM1 moves laterally into the lipid bilayer after synthesis
of TM2 or after synthesis of TM2 and -3, which are transiently in
the endoplasmic reticulum lumen followed by TM4 that acts as a stop-transfer
sequence. (D) Structure of this sequence in the AE1 crystal structure,
consisting of a cytosolic helix H1 connected by a sharp bend to the
TM1 helix that begins at P403 and terminates at T431 with a slight
kink at Pro419. (E) The ensemble of 21 wild-type structures of residues
389−430 resolved by nuclear magnetic resonance (labeled WT-NMR)
has a high degree of structural variability, especially in their N-
and C-terminal regions. For the sake of clarity, they have been fitted
onto the structure of the wild-type transmembrane region using the
Cα atoms of residues 403–418. (F) The nuclear magnetic
resonance ensemble of 21 structures of SAO mutant residues 389−430
(SAO-NMR) has less structural variability, consisting predominantly
of a single helical segment. For the sake of clarity, they have been
fitted onto the structure of the wild-type transmembrane region using
the Cα atoms of residues 409–417. Model helices of the
(G) Arg384–Lys430 wild-type sequence (WT-HEL1) and (H) the
SAO deletion (SAO-HEL1) as constructed by PyMol. The kinks are due
to the proline residues at positions 403 and 419.
Role of TM1 in the synthesis
of the transmembrane domain of AE1.
(A) Structure of the transmembrane region of AE1 or Band 3. (B) Sequence
alignment between the sequences of the wild type and the SAO mutant
in the region of TM1. The SAOAE1 mutant is missing nine residues
(Ala400–Ala408) from the N-terminus of transmembrane segment
1 (TM1). The numbering refers to the wild-type sequence. The three
proline residues are highlighted, as are two key aspartate residues.
(C) Scanning N-glycosylation mutagenesis experiments[35] suggest TM1 acts as a signal-anchor sequence during AE1
biosynthesis. TM1 moves laterally into the lipid bilayer after synthesis
of TM2 or after synthesis of TM2 and -3, which are transiently in
the endoplasmic reticulum lumen followed by TM4 that acts as a stop-transfer
sequence. (D) Structure of this sequence in the AE1 crystal structure,
consisting of a cytosolic helix H1 connected by a sharp bend to the
TM1 helix that begins at P403 and terminates at T431 with a slight
kink at Pro419. (E) The ensemble of 21 wild-type structures of residues
389−430 resolved by nuclear magnetic resonance (labeled WT-NMR)
has a high degree of structural variability, especially in their N-
and C-terminal regions. For the sake of clarity, they have been fitted
onto the structure of the wild-type transmembrane region using the
Cα atoms of residues 403–418. (F) The nuclear magnetic
resonance ensemble of 21 structures of SAO mutant residues 389−430
(SAO-NMR) has less structural variability, consisting predominantly
of a single helical segment. For the sake of clarity, they have been
fitted onto the structure of the wild-type transmembrane region using
the Cα atoms of residues 409–417. Model helices of the
(G) Arg384–Lys430 wild-type sequence (WT-HEL1) and (H) the
SAO deletion (SAO-HEL1) as constructed by PyMol. The kinks are due
to the proline residues at positions 403 and 419.Southeast Asian ovalocytosis (SAO) is an inherited condition
caused
by a nine-amino acid deletion [residues Ala400–Ala408 (Figure B)] in the boundary
between the cytosolic domain and the first transmembrane segment (TM1)
of AE1.[14−16] SAO Band 3 is incapable of mediating anion transport[14,17] and is unable to bind anion transport inhibitors such as stilbene
disulfonates.[18,19] Individuals with SAO are heterozygotes,
and their red cells contain both SAO (45%) and normal (55%) AE1. Their
anion transport activity is severely reduced (∼50% of normal[20]) because of the presence of nonfunctional SAOAE1. AE1 is a dimer, and the presence of SAOAE1 in the heterodimer
affects the structure, transport, and inhibitor binding properties
of the normal subunit.[20−22] SAOAE1 exhibits a circular dichroism spectrum similar
to that of normal AE1, suggesting that there is little difference
in secondary structure.[18,19] Interestingly, differential
thermal calorimetry studies of SAO membranes have shown that SAOAE1
does not undergo the thermal transition exhibited by normal AE1.[18] These studies indicate that although the TM
helices of SAOAE1 are formed they are not packed together properly.
As convincingly shown by the recent crystal structure,[13] the dimer interface consists of a four-helix
bundle consisting of TM5 and -6 from the gate domain and does not
involve TM1 directly, which is located in the core domain. It is therefore
plausible that the gate domain is folded correctly, allowing dimer
formation, while the core domain is disordered, and is akin to a molten
globule.The level of expression of SAOAE1 in transfected HEK
and MDCK
cells is lower than that of normal AE1, and the misfolded protein
is retained in the endoplasmic reticulum (ER) where it is subjected
to more rapid degradation.[23] SAOAE1 can,
however, form heterodimers with normal AE1, facilitating its trafficking
to the cell surface.[23,24] SAOAE1 can also be transported
to the cell surface in K562 cells that express glycophorin A.[25] Glycophorin A interacts with AE1 in the ER[26] and is known to facilitate the trafficking of
AE1 to the cell surface.[27−30] Arg61 in glycophorin A is proposed to interact directly
with Glu658 in AE1 to create the Wright (Wr) blood group antigen.[31] The abundant expression of SAOAE1 in red cells
indicates that trafficking of the protein to the plasma membrane in
red cell precursors is not severely impaired likely because of its
interaction with glycophorin A and heterodimer formation.TM1
in AE1 acts as a signal-anchor sequence to target the nascent
chain to the ER and mediates cotranslational insertion of the growing
polypeptide into the membrane.[32−34] During AE1 biosynthesis, TM1
can move laterally into the lipid bilayer in its proper orientation
only after the synthesis of TM2 and the short loop connecting it to
TM1 (Figure C). Scanning
N-glycosylation mutagenesis and cell-free translation experiments[35] have localized the C-terminal end of the hydrophobic
span of TM1 to Phe423 during AE1 biosynthesis.[9] Stable integration of TM2 into the membrane to act as a stop-transfer
sequence requires the signal sequence properties of TM1; however,
an overly long intervening sequence allowed translocation of TM2 into
the ER lumen.[36,37] N-Glycosylation sites engineered
into TM2 could be N-glycosylated in the cell-free translation system,
leading to the suggestion that TM2 and TM3 form a re-entrant loop
that is transiently exposed to the ER lumen during biosynthesis but
folds into the protein at a later stage.[9] Thus, TM1 may not insert into the lipid bilayer until after the
synthesis of TM4 (Figure C), which acts as an efficient stop-transfer sequence.[36] Regardless of the point at which TM1 moves out
of the translocon, it is located within the lipid bilayer before the
majority of AE1 synthesis is completed. Indeed, TM1 expressed alone
can act as a signal anchor, target the ER, and insert into the membrane
in its proper orientation.[36,38]Hydrophobicity
plot analyses suggest that TM1 begins at Val405
and extends to Phe423, creating a 19-amino acid hydrophobic segment
long enough to span the hydrophobic core of a lipid bilayer as an
α-helix.[8] In the crystal structure
of AE1, the TM1 helix begins at Pro403 and ends at Thr431.[13] Ensembles of structures of both wild-type TM1
[residues 389–430, labeled WT-NMR (Figure E)] and the SAO deletion mutant [SAO-NMR
(Figure F)] in a 1:1
(v/v) chloroform/methanol detergent have been resolved by nuclear
magnetic resonance (NMR).[39] These structures
are missing the RDIRR sequence at the N-terminus that, because of
its charged nature, is likely to lie at the interface between the
lipids and water.The hydrophobic length of TM1 was found to
be critical for efficient
membrane insertion of AE1, and the SAO deletion compromised this function.[38] The same region of SAOAE1 was poorly N-glycosylated,
showing that TM1 was impaired in its ability to function as a signal-anchor
sequence.[9,40] Scanning N-glycosylation of AE1 and SAOAE1 containing an insertion in EC loop 2 to allow efficient N-glycosylation
showed that the positions of the C-terminal ends of TM1 in SAOAE1
in the ER membrane were the same as in wild-type AE1.[40] This suggests that TM1 in SAOAE1 assumes a transmembrane
disposition by pulling in polar residues from the cytosolic side into
the membrane.In this paper, we studied the effect of the SAO
deletion on the
structure and dynamics of TM1 of AE1 in a model membrane using molecular
dynamics (MD) simulations. Our approach was to simulate the dynamics
of a peptide corresponding to residues 384–430, which includes
the hydrophobic core of TM1, in a phospholipid bilayer, and thereby
to study the behavior of TM1 in the ER membrane during the biosynthesis
of AE1. All simulations were repeated with the SAO mutant to determine
the effect of this deletion on the interaction of the shortened TM1
of AE1 with the lipid bilayer. Our results provide the first view
of the segmental dynamics of signal-anchor TM1 in a lipid bilayer
and the effect of a deletion mutation linked to a red cell shape change
that disrupts the proper folding of AE1.
Methods
Model
helices of sequences Arg384–Lys430 and Arg389–Lys430
were constructed using PyMol. The ensembles of the NMR structures[39] for the sequence Arg383–Lys430 were downloaded
from the Protein Data Bank (PDB entries 1BNK and 1BNX, respectively). The relevant structure
was first converted to a MARTINI coarse-grained representation[41] by version 2.4 of the martinize Python script[42] with an elastic network applied between all
beads that were within 0.5 and 0.9 nm of one another. The force constant
was 500 kJ mol–1 nm–2. The resulting
coarse-grained peptide was then placed at the center of a box with
dimensions of 0.95 nm × 0.95 nm × 0.70 nm. The energy of
the system was then minimized for 10 steps using version 4.6.x of
the GROMACS molecular dynamics package,[43] and 180 coarse-grained 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) lipids were randomly added, ensuring no clashes. A simple POPClipid bilayer was chosen because it is a major component of erythrocyte
membranes. No additional lipid species were added because the lateral
diffusion of lipids is a slow process and hence would not be resolved
by our molecular dynamics simulations performed here. The z dimension of the box was increased to 1.1 nm, and all
the coordinates were moved up by 0.2 nm, thereby leaving a 0.2 nm
gap above and below the lipids. A large number of water beads (5000)
were then added, again randomly. The energy of the system was again
minimized using the steepest descent algorithm until machine precision
was reached. Then the dynamics of the system was simulated for 10
ns using an integration time step of 20 fs. This was found to be sufficient
to allow the lipid bilayer to form. The gaps at the top and bottom
of the box introduced a bias ensuring the bilayer always formed in
the x–y plane, simplifying subsequent analysis.
Standard parameters for a MARTINI MD simulation were used. A Verlet
cutoff scheme was employed, while van der Waals interactions were
cut off at 1.2 nm with a switching function applied from 0.9 nm. Electrostatic
forces were calculated using the reaction-field method with a cutoff
of 1.5 nm and a relative dielectric constant of 15. The dielectric
constant beyond the cutoff was set to infinity. A Berendsen thermostat
applied separately to the lipids, protein, and solvent with a relaxation
time of 1.0 ps was used to maintain the temperature at 310 K. The
pressure was held at 1.0 bar using a Berendsen barostat applied semi-isotropically
with a relaxation time of 2.0 ps and a compressibility of 3 ×
10–4 bar–1.The final frame
from this self-assembly simulation[44] was
then converted back to an atomistic representation,[45] with the protein having neutral termini and
protonating Asp396 and Asp399 as required. This conversion procedure
occasionally failed because of steric clashes between the protein
and lipids (Table ). The GROMOS53a6 atomistic force field was used.[46] A short 0.1 ns molecular dynamics simulation with the position
of the protein restrained was run before a 10 ns unrestrained molecular
dynamics simulation. Both simulations used an integration time step
of 2 fs with the lengths of all bonds involving a hydrogen restrained
using the LINCS algorithm. A Verlet cutoff scheme was used, and electrostatic
forces were calculated using the particle mesh Ewald method using
a real space cutoff of 1.2 nm. van der Waals forces were cut off at
1.2 nm. The temperature was maintained at 310 K using a Langevin thermostat
with a relaxation time of 2 ps. Finally, the pressure was held at
1 bar by a Berendsen barostat applied semi-isotropically with a relaxation
time of 1 ps and a compressibility of 4.46 × 10–5 bar–1.
Table 1
Details of the MD
Simulationsa
sequence
ID
initial structure(s)
D396 and D399 protonated
no. of repeats
no. of completed MD
no. inserted
wild-type
WT-HEL1
helix with RDIRR
no
50
39
22
WT-HEL2
helix
no
50
41
23
WT-NMR
NMR ensemble
no
63
60
43
SAO deletion
SAO-HEL1
helix with RDIRR
yes
50
48
40
SAO-HEL2
helix
yes
50
46
36
SAO-NMR
NMR ensemble
yes
63
58
40
SAO-HEL1*
helix with RDIRR
no
50
48
34
SAO-HEL2*
helix
no
50
48
34
SAO-NMR*
NMR ensemble
no
63
58
39
total
489
446
311
The alphanumeric ID is used to
refer to the different sets of simulations. Three different sets of
initial structures are used to seed the MD simulations: a model helix
covering Arg384–Lys430 (HEL1), an ensemble of all 21 structures
covering Arg389–Lys430 determined by NMR (NMR), and, to allow
comparison, a second model helix covering Arg389–Lys430 (HEL2).
Fifty simulations of each of the model helices were run, while each
of the structures in the NMR ensembles was repeated three times, making
a total of 63 simulations. A proportion of simulations fail to reach
completion. Of these, a further subset does not have the protein in
a transmembrane orientation and is therefore discarded from subsequent
analysis. Because it appears that the SAO deletion mutation causes
Asp396 and Asp399 to enter the lipid bilayer, we assume that these
residues are protonated and therefore neutral. To check the effect
of this assumption, all the SAO deletion mutation simulations were
repeated with Asp396 and Asp399 in their default charged state. These
simulations are marked with asterisks.
The alphanumeric ID is used to
refer to the different sets of simulations. Three different sets of
initial structures are used to seed the MD simulations: a model helix
covering Arg384–Lys430 (HEL1), an ensemble of all 21 structures
covering Arg389–Lys430 determined by NMR (NMR), and, to allow
comparison, a second model helix covering Arg389–Lys430 (HEL2).
Fifty simulations of each of the model helices were run, while each
of the structures in the NMR ensembles was repeated three times, making
a total of 63 simulations. A proportion of simulations fail to reach
completion. Of these, a further subset does not have the protein in
a transmembrane orientation and is therefore discarded from subsequent
analysis. Because it appears that the SAO deletion mutation causes
Asp396 and Asp399 to enter the lipid bilayer, we assume that these
residues are protonated and therefore neutral. To check the effect
of this assumption, all the SAO deletion mutation simulations were
repeated with Asp396 and Asp399 in their default charged state. These
simulations are marked with asterisks.Table describes
how many simulations were run. Fifty repeats of each of the model
helices were tried, and three repeats of each of the 21 structures
in the NMR ensemble, making a total of 63, were also run. Simulations
were not included in the final analysis either because they failed
to complete the pipeline, usually because the conversion back to atomistic
coordinates was not successful, or because the sequence did not adopt
a transmembrane orientation. This was defined as the sequence having
Cα atoms 1.4 nm above and below the midplane of the bilayer
at the end of the self-assembly process.Between 44 and 88%
of simulations satisfied the criteria described
above (Table ). These
were then analyzed as follows. First the sequence was divided into
segments, as defined in Figures –4. For each frame of
the trajectory, the upper and lower leaflets and the midplane of the
membrane were defined using the phosphate atoms of the lipids. Then
the helicity of each segment was determined using the STRIDE algorithm.[47] The helical axis of the segment was calculated
by finding the first eigenvector of the backbone heavy atoms. It is
defined as pointing toward the C-terminus. The tilt angle can then
be calculated using linear algebra. Next the depth of the segment
is calculated by subtracting the membrane midplane from the center
of mass of the segment. All atoms within 0.6 nm of each residue were
examined to determine the local environment, such as the accessibility
to water. The depth of each residue, relative to the membrane midplane,
was also calculated. All this analysis was performed in Python using
the MDAnalysis[48] module. Graphs were plotted
using gnuplot, and all images were rendered using VMD.
Figure 2
The wild-type TM1 peptide is highly dynamic and samples an ensemble
of conformations. (A) The peptide remains mostly helical during the
ensemble of 50 filtered simulations. As expected, the proline residues
initiate regions of high helicity. We therefore defined three segments
that each started from one of the three proline residues: an interfacial
amphipathic helical segment (H1) and two transmembrane helical segments
(TM1a and TM1b). (B) Illustrative snapshot taken from the end of the
one of the molecular dynamics simulations. The peptide is colored
according to panel A. The positions of the phosphate groups of the
lipid bilayer are denoted with empty circles. Note the distortion
of the inner leaflet of the bilayer induced by the peptide. (C) To-scale
schematic representation of the average conformation with segment
tilts, lengths, and helicity annotated. The average extent of the
lipid bilayer as defined by the positions of the phosphate atoms is
shaded gray. (D) Density plot showing the variation in the depth and
tilt angle of the three segments of the peptide. The center of mass
of TM1a (colored red) remains close to the center of the lipid bilayer
at Phe411, and the segment explores tilt angles between 0° and
50°, centered around ∼20°.
Figure 4
Effect of deletion of
residues Ala400–Ala408 in the SAO
mutant on the position and dynamics of the TM1 peptide in the lipid
bilayer. (A) To facilitate comparison, the wild-type sequence was
divided into four sequences: an interfacial amphipathic segment (H1)
and a short transmembrane segment (TM1b) that are also present in
the SAO mutant and two central transmembrane segments (SAO and ΔTM1a).
The SAO segment consists of the nine residues that are deleted in
the mutant, and the ΔTM1a segment is the TM1 segment without
the six residues at the N-terminus. The colors defined here are used
throughout this figure. Illustrative snapshots, to-scale schematics
of the average conformations, with the lengths, tilts, and helicity
of each segment labeled, and density plots showing the variation in
the depth and tilt angle of all segments for (B) the wild-type sequence
and (C) the SAO deletion mutant. Note that the H1 segment is pulled
into the lipid bilayer in the SAO peptide, as well as the TM1b segment,
to compensate for the nine-amino acid deletion.
Results
A single transmembrane helix, such as TM1 of AE1, is likely to
be more dynamic on its own in a lipid bilayer, as will be the case
during biosynthesis, than when confined within the full transmembrane
protein. This variation in conformation sampled by the sequence Arg384–Lys430,
which includes TM1, makes it well-suited to being studied by molecular
dynamics simulation. Although there are two ensembles of NMR structures
for the wild-type sequence [Arg389–Lys430, labeled WT-NMR (Figure E and Table )] and the corresponding SAO
deletion [SAO-NMR (Figure F)] that we used in our simulations, it is likely that at
least some members of these ensembles are not representative of native
conformational states due to the nonphysiological solvent mixture
of chloroform and methanol [1:1 (v/v)].[39] We therefore also constructed two model α-helices, one with
the extended RDIRR sequence at the N-terminus [WT-HEL1 (Figure G)] and one without the extension
(WT-HEL2). The latter has the same sequence as the NMR structure [WT-NMR
(Figure E)], facilitating
direct comparison. The slight kinks in the model helices are introduced
by the three proline residues that cannot participate in backbone
hydrogen bonding.Together with the ensembles of NMR structures
(21 each for the
WT-NMR and SAO-NMR peptides), these structures form a set of putative
initial conformations for the wild-type sequence. SAO deletion variants
of the longer [SAO-HEL1 (Figure H)] and shorter (SAO-HEL2) helices as well as the NMR
ensemble (SAO-NMR) of structures were also considered. Because the
deletion of residues Ala400–Ala408 is likely to result in Asp396
and Asp399 entering the hydrophobic core of the lipid bilayer, we
have assumed that these residues are protonated in the SAO mutant.
To check the effect of this assumption, we repeated all the SAO deletion
simulations with both these residues in their default, charged state;
these are labeled SAO-HEL1*, SAO-HEL2*, and SAO-NMR*.In the
remainder of the paper, we shall focus on the behavior of
the sequence Arg389–Lys430 assuming it adopts an initial helical
conformation [WT-HEL1 (Table )] and the corresponding SAO deletion with both Asp396 and
Asp399 protonated (SAO-HEL1). Where appropriate, we compared to the
results for the wild-type sequence and SAO deletion mutant that were
modeled as a α-helix without the N-terminal RDIRR motif (WT-HEL2
and SAO-HEL2) or the ensemble of NMR structures (WT-NMR and SAO-NMR).
Because it is likely that an individual simulation could become trapped
in a metastable conformation, we ran a large number of simulations
and analyzed their statistical behavior. Fifty simulations of either α-helix
were run (Table ).
Because each NMR ensemble contains 21 structures, three repeats of
each were run, making 63 simulations for each ensemble. Overall, therefore,
489 simulations were run, each 10 ns long, making in total 4.46 μs
of dynamics.We started by assuming that the sequence spans
the membrane once,
and therefore, the first step was to embed the different structures
in our set of putative conformations into a membrane, in this case
a simple POPClipid bilayer as described in Methods. To allow each conformation to relax, the first half of each trajectory
was then discarded and the resulting data set analyzed. Our rationale
is that repeating and analyzing many, short simulations of the sequence
Arg384–Lys430 is likely to better sample the dynamics than
running a few, much longer simulations.[49]
The
Sequence R384–K430 Is, on Average, Helical in the
Membrane but Is Highly Dynamic
Twenty-two of the initial
50 WT-HEL1 simulations were successfully embedded and simulated for
10 ns in a transmembrane orientation in a POPClipid bilayer. Examining
the average helicity of this ensemble (Figure A) shows that,
as one might expect, the sequence is mainly helical with the termini
being less helical, in agreement with the NMR studies. The three prolines
(Pro391, Pro403, and Pro419) all approximately mark the start of a
local region of increased helicity. To simplify the task of analyzing
the ensembles of simulations, we defined three segments (Figure A) that are mainly
helical and start at each of these proline residues (H1, TM1a, and
TM1b). The center of mass (COM) of the first segment (H1) tends, on
average, to be found at the interface of the lipid bilayer and the
cytoplasm; we define the interface by the position of the phosphate
atoms in the POPClipids. It adopts an angle of 66° relative
to the bilayer normal and is 81% helical, on average, and therefore
can be described as an interfacial helix, which is not surprising
considering its amphipathic nature. The next two segments form a kinked
helix spanning the bilayer and are therefore labeled TM1a and TM1b.
TM1a is longer and more helical, and its COM is approximately at the
center of the bilayer. It is slightly tilted, making an angle of 27°,
on average, with the bilayer normal. TM1b is much shorter and less
helical, and its COM is close to the extracellular side of the membrane.
Like H1, it is tilted away from the membrane normal, making an angle
of 60° on average. TM1a and TM1b therefore form a kinked transmembrane
helix.The wild-type TM1 peptide is highly dynamic and samples an ensemble
of conformations. (A) The peptide remains mostly helical during the
ensemble of 50 filtered simulations. As expected, the proline residues
initiate regions of high helicity. We therefore defined three segments
that each started from one of the three proline residues: an interfacial
amphipathic helical segment (H1) and two transmembrane helical segments
(TM1a and TM1b). (B) Illustrative snapshot taken from the end of the
one of the molecular dynamics simulations. The peptide is colored
according to panel A. The positions of the phosphate groups of the
lipid bilayer are denoted with empty circles. Note the distortion
of the inner leaflet of the bilayer induced by the peptide. (C) To-scale
schematic representation of the average conformation with segment
tilts, lengths, and helicity annotated. The average extent of the
lipid bilayer as defined by the positions of the phosphate atoms is
shaded gray. (D) Density plot showing the variation in the depth and
tilt angle of the three segments of the peptide. The center of mass
of TM1a (colored red) remains close to the center of the lipid bilayer
at Phe411, and the segment explores tilt angles between 0° and
50°, centered around ∼20°.As one might expect for an isolated transmembrane sequence,
this
average conformation hides a considerable degree of dynamics. If we
characterize each segment by a coordinate consisting of its tilt and
COM depth, then the resulting density plot (Figure D) suggests that the depth of the COM of
all three segments varies by ∼1 nm and H1, TM1a, and TM1b explore
a wide range of tilt angles (0–100°, 0–50°,
and 45–100°, respectively). Taking the average and dynamical
descriptions together gives us a more complete picture of the behavior
of the sequence Arg384–Lys430 in a lipid bilayer. A similar
image emerges if we examine the simulations of the shorter model helix
[WT-HEL2 (Figure S1)] or the ensemble of
NMR conformations [WT-NMR (Figure S2)].
There are, however, some notable differences. Removing the RDIRR sequence
from the model helix appears to allow the H1 segment to explore a
wider range of conformations (Figure S1) and reduces its helicity. This is consistent with the charged RDIRR
sequence interacting with the lipids and thereby restricting the dynamics
of the H1 segment. The behavior of the flanking segments, H1 and TM1b,
is different when the simulations of the ensemble of wild-type NMR
structures are analyzed (Figure S2). The
helicity of both segments is reduced, and they explore a far wider
range of tilt angles, resulting in an average tilt angle of 108°
for the H1 segment. These differences are likely due to bias introduced
by some of the conformations present in the NMR ensemble: in several
of these, the N- and C-termini are bent around sufficiently that they
will be initially embedded within the lipid bilayer. Although this
conformation is probably unstable, it is highly likely that the simulations
are not long enough to allow the termini to escape the bilayer (see,
for example, Figure S2B), and hence, the
overall behavior is biased. We attribute this behavior of the peptide
in the NMR experiment to the nonphysiological solvent mixture used.
The SAO Deletion Results in a Helical, Dynamical Transmembrane
Peptide
Now let us consider how the SAO-HEL1 ensemble behaves.
Like the wild-type sequence, it is predominantly helical (Figure A) with fraying at both termini. Crucially, one of the prolines
(Pro403) is missing in the mutant, leading to two rather than three
segments, starting at Pro391 and Pro419. The first segment, which
we call TM1a′, is composed of the residues that make up H1
in the wild-type sequence and the second half of the TM1a sequence.
It retains a helicity of 94% (Figure C), and its COM is 0.8 nm below the midplane of the
lipid bilayer, on average. TM1a′ is more tilted than TM1a in
the wild-type sequence, making an angle of 34°, on average, with
the bilayer normal. The second segment, TM1b, comprises the same residues
as the wild-type sequence and behaves similarly with one exception:
while it has an average helicity of 76% and an average tilt angle
of 60%, the COM is only 0.9 nm, on average, above the bilayer midplane,
a shift of 0.4 nm closer to the center of the bilayer. Like that of
the wild-type sequence, this average behavior hides a high degree
of dynamics. The vertical position of the COMs of both segments varies
by up to 1.5 nm, while the TM1a′ segment explores tilt angles
in the range of 10–55° and the TM1b segment, like the
wild type, a wider range of tilt angles (10–130°). A similar
picture is observed when we analyze either the ensemble of simulations
started from the shorter model helix [SAO-HEL2 (Figure S3)] or the ensemble of simulations started from the
NMR structures [SAO-NMR (Figure S4)]. Interestingly,
the TM1b segment is both more helical and less dynamic when the RDIRR
sequence is absent (Figure S3D), suggesting
that the latter binds more strongly to the bilayer, as one might expect;
therefore, when it is present, it anchors the sequence, leaving the
TM1b segment more free, whereas when it is absent, the TM1b segment
instead interacts more closely with the bilayer. This analysis assumes
that Asp396 and Asp399 in TM1a′ are protonated and therefore
neutral. If they are deprotonated, the overall effect is to reduce
the helicity in the vicinity of these two residues (Figures S5–S7) and pull both the TM1a′ and TM1b
segments toward the cytoplasmic side of the membrane.
Figure 3
The SAO deletion mutant
peptide also samples an ensemble of conformations.
(A) The peptide remains mostly helical during the ensemble of 50 filtered
simulations. As expected, proline and glycine residues initiate and
terminate regions of high helicity. Two putative transmembrane segments
were defined, each starting from one of the two proline residues,
a central segment (TM1a′) and a shorter segment identical to
that found in the wild-type sequence (TM1b). (B) Illustrative snapshot
taken from the end of one of the molecular dynamics simulations. The
peptide is colored according to panel A. The positions of the phosphate
groups of the lipid bilayer are shown as empty circles. (C) To-scale
schematic representation of the average conformation with segment
tilts, lengths, and helicity annotated. The average extent of the
lipid bilayer as defined by the phosphate atoms is shaded gray. (D)
Density plot showing the variation in the depth and tilt angle of
both segments. The center of mass of the larger transmembrane segment
(TM1a′, colored dark blue) remains on average 0.8 nm below
the center of the lipid bilayer, and the segment explores tilt angles
between 10° and 60°, centered around ∼35°.
The SAO deletion mutant
peptide also samples an ensemble of conformations.
(A) The peptide remains mostly helical during the ensemble of 50 filtered
simulations. As expected, proline and glycine residues initiate and
terminate regions of high helicity. Two putative transmembrane segments
were defined, each starting from one of the two proline residues,
a central segment (TM1a′) and a shorter segment identical to
that found in the wild-type sequence (TM1b). (B) Illustrative snapshot
taken from the end of one of the molecular dynamics simulations. The
peptide is colored according to panel A. The positions of the phosphate
groups of the lipid bilayer are shown as empty circles. (C) To-scale
schematic representation of the average conformation with segment
tilts, lengths, and helicity annotated. The average extent of the
lipid bilayer as defined by the phosphate atoms is shaded gray. (D)
Density plot showing the variation in the depth and tilt angle of
both segments. The center of mass of the larger transmembrane segment
(TM1a′, colored dark blue) remains on average 0.8 nm below
the center of the lipid bilayer, and the segment explores tilt angles
between 10° and 60°, centered around ∼35°.
The SAO Deletion Causes
the N- and C-Termini To Be Pulled into
the Membrane by Five and Four Residues, Respectively
Overall,
a picture is emerging from the simulations of the SAO deletion causing
the C-terminus to be pulled into the lipid bilayer. To gain a more
detailed view, we need to make a direct comparison between the wild-type
sequence and the SAO deletion mutant. To achieve this, let us define
segments that are the same in both sequences (Figure A). The wild-type
sequence is then described by the behavior of four segments: H1 as
before, then the SAO sequence, the remainder of TM1a, which we call
ΔTM1a, and TM1b, also as described above. The SAO deletion mutant
is therefore identical, except the nine-residue SAO segment is missing.
Repeating exactly the same analysis as before and considering first
the average and then the dynamical behavior show that the average
effect of the deletion is for the H1 segment to be pulled into the
lipid bilayer from the cytoplasmic side by 0.6 nm on average (Figure B,C) and for the
ΔTM1a and TM1b segments to be pulled into the lipid bilayer
from the extracellular side by 0.5 and 0.4 nm, respectively. The average
conformations of the ΔTM1a and TM1b segments are not significantly
altered; however, the H1 segment becomes slightly more helical, and
the tilt angle decreases from 66° to 40°. All segments remain
highly dynamic, with those firmly embedded in the lipid bilayer (SAO
and ΔTM1a) displaying a variation in tilt angles smaller than
those of the other segments (H1 and TM1b). Similar trends are seen
when the simulations starting from the shorter model helix or the
ensembles of NMR structures are analyzed (Figures S8 and S9). Our overall picture is now more nuanced: the SAO
deletion causes both ends of the protein to be pulled into the lipid
bilayer by approximately the same amount, causing the N-terminus to
be become more helical, thereby forming an approximately continuous
helical region with the ΔTM1a segment, as shown in Figure .Effect of deletion of
residues Ala400–Ala408 in the SAO
mutant on the position and dynamics of the TM1 peptide in the lipid
bilayer. (A) To facilitate comparison, the wild-type sequence was
divided into four sequences: an interfacial amphipathic segment (H1)
and a short transmembrane segment (TM1b) that are also present in
the SAO mutant and two central transmembrane segments (SAO and ΔTM1a).
The SAO segment consists of the nine residues that are deleted in
the mutant, and the ΔTM1a segment is the TM1 segment without
the six residues at the N-terminus. The colors defined here are used
throughout this figure. Illustrative snapshots, to-scale schematics
of the average conformations, with the lengths, tilts, and helicity
of each segment labeled, and density plots showing the variation in
the depth and tilt angle of all segments for (B) the wild-type sequence
and (C) the SAO deletion mutant. Note that the H1 segment is pulled
into the lipid bilayer in the SAO peptide, as well as the TM1b segment,
to compensate for the nine-amino acid deletion.To more precisely determine how much each end of the sequence
moves
in response to the SAO deletion, we have calculated the average distance
of each residue relative to the midplane of the lipid bilayer over
all the simulations in each ensemble (Figure A). This shows that, on average, the N-terminus
is pulled in by five residues and the C-terminus is pulled in by four
residues. Repeating this analysis for the simulations seeded by either
the shorter model helix or the ensemble of NMR structures yields similar
but not identical patterns; the former suggests the N- and C-termini
are pulled in by six and three residues, respectively, while the latter
suggests that the eight residues of the N-terminus are pulled into
the bilayer (Figure S10). We treat the
latter result with caution because of the previously noted problems
with trapped structures and equilibration. Taken together, these results
suggest that while both termini are pulled into the bilayer, the effect
is stronger at the N-terminus than at the C-terminus. This conclusion
assumes both Asp396 and Asp399 are protonated; repeating the analysis
with both residues charged alters the behavior. For either model helix,
the N-terminus is now only pulled into the bilayer by three residues
on average (Figure S11), while the C-terminus
is pulled in by six residues. As described above, the effect is different
for the ensemble of NMR structures where the N- and C-termini are
pulled in by six and three residues, respectively.
Figure 5
Structure of the transmembrane
segment of the SAO deletion mutant
that is different from the structure of wild-type TM1. (A) Average
distance from the central plane of the lipid bilayer for each residue
in both the wild-type and SAO deletion mutant sequences. This analysis
suggests that deleting the nine residues causes the N-terminus to
shift toward the extracellular side by five residues and the C-terminus
to shift toward the intracellular side by four residues. (B) Shifting
the sequence by these amounts allows us to find the sequence in the
SAO mutant equivalent to the TM1 segment in the wild type. (C) Comparing
the ensemble of structures generated by the simulations with the structure
of TM1 found in the full AE1 structure shows that the equivalent sequence
in the SAO mutant both is more different on average, with higher root-mean-square
deviation values, and rarely samples conformations similar to that
seen in the experimental structure of the transmembrane part of AE1.
Structure of the transmembrane
segment of the SAO deletion mutant
that is different from the structure of wild-type TM1. (A) Average
distance from the central plane of the lipid bilayer for each residue
in both the wild-type and SAO deletion mutant sequences. This analysis
suggests that deleting the nine residues causes the N-terminus to
shift toward the extracellular side by five residues and the C-terminus
to shift toward the intracellular side by four residues. (B) Shifting
the sequence by these amounts allows us to find the sequence in the
SAO mutant equivalent to the TM1 segment in the wild type. (C) Comparing
the ensemble of structures generated by the simulations with the structure
of TM1 found in the full AE1 structure shows that the equivalent sequence
in the SAO mutant both is more different on average, with higher root-mean-square
deviation values, and rarely samples conformations similar to that
seen in the experimental structure of the transmembrane part of AE1.
Unlike That of the Wild-Type
Sequence, the Transmembrane Helix
of the SAO Deletion Mutant Rarely Resembles TM1 in the Structure of
AE1
Using this result, we can align residues in both the
wild-type and SAO deletion mutant sequences based on their depth in
the membrane (Figure B). This shows that, for example, Tyr403 in the SAO mutant is found
at the same depth as Val409 in the wild-type sequence, allowing us
to identify the residues in the SAO deletion mutant equivalent in
terms of their depth in the bilayer to those of the TM1a segment of
the wild type. If we consider the biosynthesis of AE1 for a moment,
then TM1 will be the first transmembrane helix ejected from the translocon
into the membrane (Figure C). As our simulations suggest, it is likely that TM1 on its
own is highly dynamic once it moves into the lipid bilayer. It is,
however, reasonable to assume that TM1 samples, perhaps only occasionally,
the conformation it ultimately adopts in the folded structure of the
whole AE1 transmembrane protein. If this were not true, it would imply
either that the structure adopted by TM1 in the whole protein has
a high energy, and is therefore not favored, or that the local environment
around TM1 in the folded protein is significantly different from what
it experiences immediately after synthesis. Consistent with this idea,
we find that a few (8%) of the structures sampled by TM1 in our wild-type
simulations are very similar to the conformation of the same residues
in the full AE1 structure, as defined by having a Cα root-mean-square
deviation of <0.05 nm. The conformations adopted by the equivalent
residues in the SAO deletion mutant are on average more different
and also very rarely (0.2%) sample conformations similar to that adopted
by TM1 in the full AE1 structure. This hints at the disruptive effect
of deleting residues Ala400–Ala408 on the biosynthesis and
proper folding of AE1.
Discussion
The red blood cells of
heterozygotes with SAO have an abnormal
shape and exhibit an ∼50% decrease in their level of anion
transport because of the presence of nonfunctional SAOAE1. SAO results
from a nine-residue deletion at the N-terminal end of TM1 of AE1,
which removes a bend in the protein chain resulting in a misfolded
protein (Figure B).
TM1 acts as a signal-anchor sequence targeting the nascent chain to
the ER, and therefore, it is important to consider the effect of this
mutation on the biosynthesis of AE1 where TM1 is initially isolated
in the membrane before the distal transmembrane segments are ejected
from the translocon and inserted into the membrane. Indeed, cell-free
translation experiments[9,36] have indicated that TM2 and -3
translocate into the ER lumen with TM4 acting as a stop-transfer sequence.
Here we have shown by extensive MD simulations that the wild-type
sequence Arg384–Lys430, which includes TM1, is predominantly
helical in conformation and can be characterized by three helical
segments: an amphipathic helix (H1) that lies at the interface between
the lipid bilayer and the cytoplasm and a transmembrane helix composed
of two helical segments that begins at Pro403 and is kinked at a conserved
proline residue (Pro419). This average view hides, however, considerable
dynamics, as expected for a single helix in a lipid bilayer. The same
overall picture is recovered if we seed the simulations with structures
resolved by NMR experiments[39] or start
with a model of the sequence as a classical α-helix (Figures , S1, and S2).Removing the nine residues that cause SAO,
Ala400–Ala408,
from near the N-terminal end of TM1 not only alters its average conformation
but also causes the N- and C-termini to be pulled into the lipid bilayer
to accommodate this deletion (Figures , S8, and S9). We estimate
this effect is more pronounced at the N-terminus with at least five
residues entering the membrane (Figures and S10). As
a consequence, the sequence adopts a single, kinked transmembrane
helix, but with no interfacial H1 helix (Figures , S3, and S4).
Starting the simulations from either a model of the sequence as a
helix or structures resolved by NMR experiments[39] leads to similar conclusions. This result assumes that
both aspartic acid residues in the H1 helix that are pulled into the
bilayer become protonated. Leaving both these N-terminal residues
in their default charged state still results in the sequence folding
into a single, kinked transmembrane helix (Figures S5–S7); however, as expected, only three residues are
pulled into the bilayer from the N-terminus (Figure S11), while six residues are pulled in from the C-terminus.In all cases, the simulations produce a transmembrane helix that
is highly dynamic. This helix ultimately becomes TM1 in the transmembrane
region of AE1.[13] By comparing the ensemble
of transmembrane structures seen in our simulations and the recent
structure of the transmembrane region of AE1,[13] we have shown that, although dynamic, the wild-type sequence occasionally
samples conformations very similar to that seen in the folded structure
of AE1. It is possible, therefore, to see how this sequence can become
incorporated into the fully folded structure of AE1. The SAO deletion,
however, leads to an ensemble of transmembrane structures that samples
conformations similar to TM1 in AE1 less frequently, and consequently,
one can see how this mutation could lead to packing defects in AE1,
leading to its physiological effects. We have noted that in the crystal
structure of the transmembrane region of AE1, the helical portion
of TM1 finishes around two helical turns later than we have seen in
our simulations at Thr431. This may be because the local environment
around TM1 in the full structure causes that region to adopt a helical
conformation.To validate these results, let us compare the
simulations to the
results of N-glycosylation scanning mutagenesis experiments by considering
the average water accessibility of each residue (Figure ). If we consider the wild-type
sequence, then, as expected, the transmembrane SAO and ΔTM1a
segments are only marginally accessible to water. Overall, as we move
farther from the central transmembrane region, the water accessibility
increases, as expected. The “sawtooth” pattern with
peaks every three or four residues seen in the N-terminus is consistent
with the formation of amphipathic helices lying at the interface between
the lipid bilayer and the solvent, as seen in the behavior of the
H1 segment (Figure ). The fact that a similar pattern with a smaller magnitude is seen
in the TM1b segment is consistent both with this sequence forming
a helix less often and with it being more buried in the bilayer (Figure ).
Figure 6
Water accessibility of
the wild-type and SAO mutant peptide. A
residue is defined as being accessible to water if at least one water
oxygen atom is found within 0.6 nm of the residue, averaged over all
the simulations. The sawtooth pattern is due to the amphipathic nature
of the H1 helix in the flanking segments, which lie approximately
perpendicular to the membrane normal with one side facing water and
the other facing the lipid bilayer. This positions polar and/or charged
residues Arg387, Arg388, Tyr392, Asp396, and Asp399 facing water and
nonpolar Ile386, Pro391, Leu394, and Ile 397 facing the lipid bilayer.
Considering the C-terminal end of TM1, our simulations predict that
the first residues that are accessible to water are Pro419 and Phe423.
Water accessibility of
the wild-type and SAO mutant peptide. A
residue is defined as being accessible to water if at least one wateroxygen atom is found within 0.6 nm of the residue, averaged over all
the simulations. The sawtooth pattern is due to the amphipathic nature
of the H1 helix in the flanking segments, which lie approximately
perpendicular to the membrane normal with one side facing water and
the other facing the lipid bilayer. This positions polar and/or charged
residues Arg387, Arg388, Tyr392, Asp396, and Asp399 facing water and
nonpolar Ile386, Pro391, Leu394, and Ile 397 facing the lipid bilayer.
Considering the C-terminal end of TM1, our simulations predict that
the first residues that are accessible to water are Pro419 and Phe423.N-Glycosylation is a cotranslational
event that occurs on the luminal
side of the ER membrane while the nascent polypeptide chain is located
within the translocon. N-Glycosylation acceptor sites must be located
a minimum of 12 and 14 residues (12 + 14 rule) from the proximal and
distal ends, respectively, of the hydrophobic regions of transmembrane
segments to be efficiently N-glycosylated in the lumen of the ER.[8] Scanning N-glycosylation mutagenesis can therefore
be used to predict the position of the lumen ends of transmembrane
segments during biosynthesis. N-Glycosylation experiments[40] using cell-free translation and transfected
HEK cells with an insertion in the short loop between TM1 and -2 in
AE1 to facilitate N-glycosylation identified Pro419 as the end of
the hydrophobic region of TM1 in both wild-type and SAOAE1. This
indicates that the position of TM1 in the translocon is the same in
wild-type and SAOAE1. The efficiency of N-glycosylation of the SAO
constructs was always lower than that of the wild-type protein, suggesting
that the SAO deletion impairs the signal-anchor function of TM1.Subsequent N-glycosylation scanning experiments using transfected
HEK cells and constructs without the insertion revealed that introduced
N-glycosylation sites within TM2 and -3 in AE1 could be N-glycosylated.
This led to the suggestions that TM2 and -3 are translocated into
the ER lumen during biosynthesis and folded into the protein as re-entrant
loops. These experiments found that the luminal end of TM1 was located
at Phe423, one helical turn more distal than Pro419, the estimate
made with the insertion constructs. Interestingly, residues Pro419
and Phe423 are the positions of the first two peaks in water accessibility
on the extracellular side of the protein, regardless of the initial
structure(s) used in the simulation (Figures and S12). This
is evidence that our simulations are accurately modeling the dynamics
of this peptide in a simple lipid bilayer, placing these residues
on the same side of a helix at the membrane interface region. In our
simulations of the sequence Arg384–Lys430 in AE1SAO, because
TM1b is pulled into the lipid bilayer (Figure B) by the deletion, the sawtooth pattern
is missing and it is not until Gly428 that the water accessibility
is >10%. We note that in the crystal structure of AE1 the helical
portion of TM1 begins at Pro403 and ends at Thr431,[13] around two helical turns later than where we have assumed
TM1b finishes, well into the aqueous phase. In addition, TM1 is buried
within the protein structure with little exposure to the lipid bilayer.
Thus, it is not surprising that the shortened TM1 segment in AE1SAO
cannot assume a native conformation, resulting in disruption of the
packing of TM segments.It is notable but not surprising that
the three proline residues
in the sequence we have considered are important in determining the
secondary structure. Because of its inability to form backbone hydrogen
bonds with the residue four positions toward the N-terminus, proline
is acknowledged as “breaking” α-helices. We observed
that local increases in the helicity tended to coincide with a proline
residue, consistent with this suggestion. These three prolines are
conserved,[1] and it has been suggested for
a long time that proline residues not only are enriched in the transmembrane
helices of transport proteins[50] but also
can play important roles in the functioning of membrane proteins.
Like their soluble cousins, proline residues in membrane proteins
can also induce helix initiation. This notion is supported by our
simulations in which the sequences distal to proline residues are
highly helical. For example, it has been suggested that straightening
the kinks introduced into a transmembrane helix by a proline is a
way of storing energy (as strain) in membrane proteins, such as transporters,
that can be unwound later in the functional cycle.[51]We have made several assumptions throughout that
it is important
to clarify. The first is that the structure of the polypeptide, including
the first transmembrane segment TM1, of AE1 can be described as a
helix, and the second is that it is preferable to run a large number
of short simulations rather than a few long simulations. Given we
obtain similar results when the simulations are seeded with structures
determined by NMR experiments,[39] these
assumptions appear to be reasonable. We have also assumed that this
polypeptide is inserted into a transmembrane orientation by the translocon;
again this is realistic given the experimental data.[32−34] Finally, we have assumed that a simple POPClipid bilayer is a good
mimic for a single helix that has been just ejected from the translocon
into the ER membrane.
Authors: Reinhart A F Reithmeier; Joseph R Casey; Antreas C Kalli; Mark S P Sansom; Yilmaz Alguel; So Iwata Journal: Biochim Biophys Acta Date: 2016-04-06
Authors: Sian T Patterson; Jing Li; Jeong-Ah Kang; Amittha Wickrema; David B Williams; Reinhart A F Reithmeier Journal: J Biol Chem Date: 2009-03-03 Impact factor: 5.157